Market By Age Groups, Education, Drugs & Devices, End Users And Geography | Forecast 2019-2027
As per Triton Market Research’s report, the Latin America contraceptives market is expected to progress at a CAGR of 7.57% during the forecast years 2019-2027.
The countries considered in the Latin America market region are:
O Brazil
O Mexico
O Rest of Latin America
The factors driving the Latin American contraceptive market are investments made by the government to create awareness about family planning, improving the quality of healthcare services and making contraceptives affordable to the public. Women are now open to adopting modern methods of contraception. Contraceptives play a huge role in evading sexually transmitted diseases and all these factors have led to the increased popularity of contraceptives. However, individuals are still skeptical towards the usage of contraceptives as they cause side-effects such as hair loss, breast tenderness, blood clots, nausea and depression among others.
Age group, education, drugs & devices and end users are the various categories into which the Latin American contraceptive market can be divided. The market as per the age group can be sub-categorized into people ranging in the ages - 15 to 24, 25 to 34, 35 to 44 and 45 and above. People forming the sub-categories of the education segment of the market are - people who are still in high school, high school graduates, college graduates and those having other college degrees. The major end users of contraceptives are – hospitals, households and clinics. Products that fall under the category of drugs and devices used in the contraceptive market are drugs such as injectables, oral pills & topical contraceptives and devices such as condoms, vaginal rings, subdermal implants, diaphragms, contraceptive sponges & IUDs.
The major contraceptives manufacturing companies are Allergan, Inc., Okamoto Industries, Inc., Cooper Surgical, Inc., Agile Therapeutics, Apothecus Pharmaceutical Corporation, Merck & Co., Inc., Mayer Laboratories, Inc., Church & Dwight Co., Inc., Teva Pharmaceutical Industries, Ltd., Ocon Medical, Ltd., Afaxys, Inc., Pfizer, Inc., Melbea, Pregna, SMB Corporation, Reckitt Benckiser PLC and Bayer AG.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. CONTRACEPTIVE
MARKET - SUMMARY
2. INDUSTRY
OUTLOOK
2.1. MARKET
DEFINITION
2.2. PORTER’S
FIVE FORCES MODEL
2.2.1. THREAT
OF NEW ENTRANTS
2.2.2. THREAT
OF SUBSTITUTE
2.2.3. BARGAINING
POWER OF BUYERS
2.2.4. BARGAINING
POWER OF SUPPLIERS
2.2.5. THREAT
OF COMPETITIVE RIVALRY
2.3. REGULATORY
OUTLOOK
2.4. PESTEL
OUTLOOK
2.5. MARKET
ATTRACTIVENESS INDEX
2.6. MARKET
PLAYER POSITIONING
2.7. KEY
INSIGHTS
2.7.1. ORAL
CONTRACEPTIVE ARE THE MAJORLY USED CONTRACEPTIVE DRUGS
2.7.2. CONDOMS
ARE THE WIDELY USED CONTRACEPTIVES DEVICE
2.7.3. AGE
GROUP OF 15–24 YEARS ARE THE MAJOR REVENUE CONTRIBUTORS TO THE LATIN AMERICA
CONTRACEPTIVE MARKET
2.8. MARKET
DRIVERS
2.8.1. GROWING
COGNIZANCE FOR CONTRACEPTIVES
2.8.2. INCREASING
USAGE OF ORAL CONTRACEPTIVES TO EVADE UNPLANNED PREGNANCY
2.8.3. SURGE
IN THE INITIATIVES OF GOVERNMENT AND NGO
2.8.4. GROWING
AWARENESS ABOUT STD
2.9. MARKET
RESTRAINTS
2.9.1. SIDE
EFFECTS RESTRICTING THE GROWTH OF CONTRACEPTIVES
2.9.2. LIMITED
ACCESS TO CONTRACEPTIVES
2.10.
MARKET OPPORTUNITIES
2.10.1.
RISING DISPOSABLE INCOME IN
EMERGING ECONOMIES
2.10.2.
UNMET MEDICAL NEEDS IN THE
EMERGING ECONOMIES
2.10.3.
TECHNOLOGICAL ADVANCEMENTS
2.11.
MARKET CHALLENGES
2.11.1.
LACK OF ACCEPTANCE OF SOCIETY
3. CONTRACEPTIVE
MARKET OUTLOOK - BY EDUCATION
3.1. LESS
THAN HIGH SCHOOL
3.2. HIGH
SCHOOL GRADUATE
3.3. COLLEGE
GRADUATE
3.4. OTHER
COLLEGE DEGREES
4. CONTRACEPTIVE
MARKET OUTLOOK - BY AGE GROUP
4.1. 15–24
YEARS
4.2. 25–34
YEARS
4.3. 35–44
YEARS
4.4. ABOVE
44 YEARS
5. CONTRACEPTIVE
MARKET OUTLOOK - BY END USER
5.1. HOUSEHOLDS
5.2. CLINICS
5.3. HOSPITALS
6. CONTRACEPTIVE
MARKET OUTLOOK - BY DRUGS AND DEVICES
6.1. CONTRACEPTIVES
DRUGS
6.1.1. ORAL
CONTRACEPTIVE PILLS
6.1.2. INJECTABLE
CONTRACEPTIVES
6.1.3. TOPICAL
CONTRACEPTIVES
6.2. CONTRACEPTIVE
DEVICES
6.2.1. MALE
CONDOMS
6.2.2. FEMALE
CONDOMS
6.2.3. DIAPHRAGMS
6.2.4. CONTRACEPTIVE
SPONGES
6.2.5. VAGINAL
RINGS
6.2.6. SUBDERMAL
IMPLANTS
6.2.7. INTRA-UTERINE
DEVICES
6.2.7.1. COPPER
INTRA-UTERINE DEVICES
6.2.7.2. HORMONAL
INTRA-UTERINE DEVICES
7. CONTRACEPTIVE
MARKET - REGIONAL OUTLOOK
7.1. LATIN
AMERICA
7.1.1. COUNTRY
ANALYSIS
7.1.1.1. BRAZIL
7.1.1.2. MEXICO
7.1.1.3. REST
OF LATIN AMERICA
8. COMPETITIVE
LANDSCAPE
8.1. COMPANY
PROFILES
8.1.1. ALLERGAN
INC.
8.1.2. BAYER
AG
8.1.3. MELBEA
8.1.4. PREGNA
8.1.5. PFIZER,
INC.
8.1.6. CHURCH
& DWIGHT CO., INC.
8.1.7. AFAXYS,
INC.
8.1.8. APOTHECUS
PHARMACEUTICAL CORPORATION
8.1.9. COOPER
SURGICAL INC
8.1.10.
OKAMOTO INDUSTRIES, INC
8.1.11.
MAYER LABORATORIES, INC.
8.1.12.
AGILE THERAPEUTICS
8.1.13.
MERCK & CO., INC.
8.1.14.
RECKITT BENCKISER PLC
8.1.15.
SMB CORPORATION
8.1.16.
TEVA PHARMACEUTICAL INDUSTRIES
LTD.
8.1.17.
OCON MEDICAL LTD
9. METHODOLOGY
& SCOPE
9.1. RESEARCH
SCOPE
9.2. SOURCES
OF DATA
9.3. RESEARCH
METHODOLOGY
TABLE 1 LATIN AMERICA CONTRACEPTIVE MARKET
2019-2027 ($ MILLION)
TABLE 2 CONTRACEPTIVE MARKET PLAYER POSITIONING OUTLOOK 2017
TABLE 3 LATIN AMERICA CONTRACEPTIVE MARKET BY
EDUCATION 2019-2027 ($ MILLION)
TABLE 4 LATIN AMERICA CONTRACEPTIVE MARKET BY
AGE GROUP 2019-2027 ($ MILLION)
TABLE 5 LATIN AMERICA CONTRACEPTIVE MARKET BY
END USER 2019-2027 ($ MILLION)
TABLE 6 LATIN AMERICA CONTRACEPTIVE MARKET BY
DRUGS AND DEVICES 2019-2027 ($ MILLION)
TABLE 7 LATIN AMERICA CONTRACEPTIVES DRUGS
MARKET BY TYPE 2019-2027 ($ MILLION)
TABLE 8 LATIN AMERICA CONTRACEPTIVE DEVICES
MARKET BY TYPE 2019-2027 ($ MILLION)
TABLE 9 LATIN AMERICA INTRA-UTERINE DEVICES
MARKET BY TYPE 2019-2027 ($ MILLION)
TABLE 10 LATIN AMERICA CONTRACEPTIVE MARKET BY
COUNTRY 2019-2027 ($ MILLION)
FIGURE 1 LATIN AMERICA CONTRACEPTIVE MARKET
2019-2027 ($ MILLION)
FIGURE 2 PORTER’S FIVE FORCE MODEL
FIGURE 3 LATIN AMERICA CONTRACEPTIVE MARKET BY LESS
THAN HIGH SCHOOL 2019-2027 ($ MILLION)
FIGURE 4 LATIN AMERICA CONTRACEPTIVE MARKET BY HIGH
SCHOOL GRADUATE 2019-2027 ($ MILLION)
FIGURE 5 LATIN AMERICA CONTRACEPTIVE MARKET BY
COLLEGE GRADUATE 2019-2027 ($ MILLION)
FIGURE 6 LATIN AMERICA CONTRACEPTIVE MARKET BY
OTHER COLLEGE DEGREES 2019-2027 ($ MILLION)
FIGURE 7 LATIN AMERICA CONTRACEPTIVE MARKET BY
15–24 YEARS 2019-2027 ($ MILLION)
FIGURE 8 LATIN AMERICA CONTRACEPTIVE MARKET BY
25–34 YEARS 2019-2027 ($ MILLION)
FIGURE 9 LATIN AMERICA CONTRACEPTIVE MARKET BY 35–44
YEARS 2019-2027 ($ MILLION)
FIGURE 10 LATIN AMERICA CONTRACEPTIVE MARKET BY ABOVE
44 YEARS 2019-2027 ($ MILLION)
FIGURE 11 LATIN AMERICA CONTRACEPTIVE MARKET BY
HOUSEHOLDS 2019-2027 ($ MILLION)
FIGURE 12 LATIN AMERICA CONTRACEPTIVE MARKET BY CLINICS
2019-2027 ($ MILLION)
FIGURE 13 LATIN AMERICA CONTRACEPTIVE MARKET BY
HOSPITALS 2019-2027 ($ MILLION)
FIGURE 14 LATIN AMERICA CONTRACEPTIVE MARKET BY
CONTRACEPTIVES DRUGS 2019-2027 ($ MILLION)
FIGURE 15 LATIN AMERICA CONTRACEPTIVES DRUGS MARKET BY
ORAL CONTRACEPTIVE PILLS 2019-2027 ($ MILLION)
FIGURE 16 LATIN AMERICA CONTRACEPTIVES DRUGS MARKET BY
INJECTABLE CONTRACEPTIVES 2019-2027 ($ MILLION)
FIGURE 17 LATIN AMERICA CONTRACEPTIVES DRUGS MARKET BY
TOPICAL CONTRACEPTIVES 2019-2027 ($ MILLION)
FIGURE 18 LATIN AMERICA CONTRACEPTIVE MARKET BY
CONTRACEPTIVE DEVICES 2019-2027 ($ MILLION)
FIGURE 19 LATIN AMERICA CONTRACEPTIVE DEVICES MARKET BY
MALE CONDOMS 2019-2027 ($ MILLION)
FIGURE 20 LATIN AMERICA CONTRACEPTIVE DEVICES MARKET BY
FEMALE CONDOMS 2019-2027 ($ MILLION)
FIGURE 21 LATIN AMERICA CONTRACEPTIVE DEVICES MARKET BY
DIAPHRAGMS 2019-2027 ($ MILLION)
FIGURE 22 LATIN AMERICA CONTRACEPTIVE DEVICES MARKET BY
CONTRACEPTIVE SPONGES 2019-2027 ($ MILLION)
FIGURE 23 LATIN AMERICA CONTRACEPTIVE DEVICES MARKET BY
VAGINAL RINGS 2019-2027 ($ MILLION)
FIGURE 24 LATIN AMERICA CONTRACEPTIVE DEVICES MARKET BY
SUBDERMAL IMPLANTS 2019-2027 ($ MILLION)
FIGURE 25 LATIN AMERICA CONTRACEPTIVE DEVICES MARKET BY
INTRA-UTERINE DEVICES 2019-2027 ($ MILLION)
FIGURE 26 LATIN AMERICA INTRA-UTERINE DEVICES MARKET BY
COPPER INTRA-UTERINE DEVICES 2019-2027 ($ MILLION)
FIGURE 27 LATIN AMERICA INTRA-UTERINE DEVICES MARKET BY
HORMONAL INTRA-UTERINE DEVICES 2019-2027 ($ MILLION)
FIGURE 28 BRAZIL CONTRACEPTIVE MARKET 2019-2027 ($
MILLION)
FIGURE 29 MEXICO CONTRACEPTIVE MARKET 2019-2027 ($
MILLION)
FIGURE 30 REST OF LATIN AMERICA CONTRACEPTIVE MARKET
2019-2027 ($ MILLION)